These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 11160613)
1. Regional differences in anandamide- and methanandamide-induced membrane potential changes in rat mesenteric arteries. Vanheel B; Van de Voorde J J Pharmacol Exp Ther; 2001 Feb; 296(2):322-8. PubMed ID: 11160613 [TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715 [TBL] [Abstract][Full Text] [Related]
3. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. White R; Hiley CR Br J Pharmacol; 1997 Dec; 122(8):1573-84. PubMed ID: 9422801 [TBL] [Abstract][Full Text] [Related]
4. Studies on the effects of anandamide in rat hepatic artery. Zygmunt PM; Högestätt ED; Waldeck K; Edwards G; Kirkup AJ; Weston AH Br J Pharmacol; 1997 Dec; 122(8):1679-86. PubMed ID: 9422814 [TBL] [Abstract][Full Text] [Related]
5. Influence of cannabinoids on the delayed rectifier in freshly dissociated smooth muscle cells of the rat aorta. Van den Bossche I; Vanheel B Br J Pharmacol; 2000 Sep; 131(1):85-93. PubMed ID: 10960073 [TBL] [Abstract][Full Text] [Related]
7. Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. del Carmen García M; Adler-Graschinsky E; Celuch SM Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):270-6. PubMed ID: 14504685 [TBL] [Abstract][Full Text] [Related]
8. Cannabinoid activation of recombinant and endogenous vanilloid receptors. Ralevic V; Kendall DA; Jerman JC; Middlemiss DN; Smart D Eur J Pharmacol; 2001 Jul; 424(3):211-9. PubMed ID: 11672565 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. White R; Ho WS; Bottrill FE; Ford WR; Hiley CR Br J Pharmacol; 2001 Oct; 134(4):921-9. PubMed ID: 11606334 [TBL] [Abstract][Full Text] [Related]
10. Methanandamide hyperpolarizes gastric arteries by stimulation of TRPV1 receptors on perivascular CGRP containing nerves. Breyne J; Vanheel B J Cardiovasc Pharmacol; 2006 Feb; 47(2):303-9. PubMed ID: 16495770 [TBL] [Abstract][Full Text] [Related]
11. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels. Grainger J; Boachie-Ansah G Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448 [TBL] [Abstract][Full Text] [Related]
12. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation. Ishioka N; Bukoski RD J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011 [TBL] [Abstract][Full Text] [Related]
13. Anandamide-induced vasorelaxation in rabbit aortic rings has two components: G protein dependent and independent. Mukhopadhyay S; Chapnick BM; Howlett AC Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2046-54. PubMed ID: 12003810 [TBL] [Abstract][Full Text] [Related]
14. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro. Wheal AJ; Bennett T; Randall MD; Gardiner SM Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361 [TBL] [Abstract][Full Text] [Related]
15. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Plane F; Holland M; Waldron GJ; Garland CJ; Boyle JP Br J Pharmacol; 1997 Aug; 121(8):1509-11. PubMed ID: 9283682 [TBL] [Abstract][Full Text] [Related]
16. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors. Járai Z; Wagner JA; Varga K; Lake KD; Compton DR; Martin BR; Zimmer AM; Bonner TI; Buckley NE; Mezey E; Razdan RK; Zimmer A; Kunos G Proc Natl Acad Sci U S A; 1999 Nov; 96(24):14136-41. PubMed ID: 10570211 [TBL] [Abstract][Full Text] [Related]
17. Comparative pharmacology of endothelium-derived hyperpolarizing factor and anandamide in rat isolated mesentery. Randall MD; McCulloch AI; Kendall DA Eur J Pharmacol; 1997 Aug; 333(2-3):191-7. PubMed ID: 9314035 [TBL] [Abstract][Full Text] [Related]
18. R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors. Nieri P; Martinotti E; Testai L; Adinolfi B; Calderone V; Breschi MC Eur J Pharmacol; 2003 Jan; 459(1):75-81. PubMed ID: 12505536 [TBL] [Abstract][Full Text] [Related]
19. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats. Malinowska B; Kwolek G; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 2001 Dec; 364(6):562-9. PubMed ID: 11770012 [TBL] [Abstract][Full Text] [Related]
20. Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed. Mendizábal VE; Orliac ML; Adler-Graschinsky E Eur J Pharmacol; 2001 Sep; 427(3):251-62. PubMed ID: 11567656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]